BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3973899)

  • 1. Structure-activity relationships of C-terminal tri- and tetrapeptide fragments that inhibit gastrin activity.
    Martinez J; Bali JP; Magous R; Laur J; Lignon MF; Briet C; Nisato D; Castro B
    J Med Chem; 1985 Mar; 28(3):273-8. PubMed ID: 3973899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenethyl ester derivative analogues of the C-terminal tetrapeptide of gastrin as potent gastrin antagonists.
    Martinez J; Rodriguez M; Bali JP; Laur J
    J Med Chem; 1986 Nov; 29(11):2201-6. PubMed ID: 3783582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological activities of some pseudo-peptide analogues of tetragastrin: the importance of the peptide backbone.
    Martinez J; Bali JP; Rodriguez M; Castro B; Magous R; Laur J; Lignon MF
    J Med Chem; 1985 Dec; 28(12):1874-9. PubMed ID: 2999406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biological activity of new peptide segments of gastrin exhibiting gastrin antagonist property.
    Martinez J; Magous R; Lignon MF; Laur J; Castro B; Bali JP
    J Med Chem; 1984 Dec; 27(12):1597-601. PubMed ID: 6094810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of gastrin antagonists, analogues of the C-terminal tetrapeptide of gastrin, by introduction of a beta-homo residue.
    Rodriguez M; Fulcrand P; Laur J; Aumelas A; Bali JP; Martinez J
    J Med Chem; 1989 Mar; 32(3):522-8. PubMed ID: 2918498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new class of potent gastrin antagonists.
    Martinez J; Bali JP
    Regul Pept; 1984 Nov; 9(4):259-62. PubMed ID: 6097950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abilities of some tryptophan and phenylalanine derivatives to inhibit gastric acid secretion.
    Magous R; Martinez J; Lignon MF; Nisato D; Castro B; Bali JP
    Biochim Biophys Acta; 1985 May; 845(2):158-62. PubMed ID: 2986716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel C-terminal gastrin antagonists. Synthesis and biological activity.
    Yasui A; Douglas AJ; Walker B; Magee DF; Murphy RF
    Int J Pept Protein Res; 1990 Apr; 35(4):301-5. PubMed ID: 2345051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological activity of partially modified retro-inverso pseudopeptide derivatives of the C-terminal tetrapeptide of gastrin.
    Rodriguez M; Dubreuil P; Bali JP; Martinez J
    J Med Chem; 1987 May; 30(5):758-63. PubMed ID: 3572963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dispensability of both the amide of phenylalanine and the carboxyl group of aspartic acid for the stimulation of gastric acid secretion by gastrin peptides in dogs.
    Lin TM; Spray GF; Southard GL
    Gastroenterology; 1977 Mar; 72(3):566-8. PubMed ID: 832807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of pseudo-peptide analogues of the C-terminal tetrapeptide of gastrin and evaluation of their biological activity on acid secretion.
    Rodriguez M; Bali JP; Magous R; Castro B; Martinez J
    Int J Pept Protein Res; 1986 Mar; 27(3):293-9. PubMed ID: 3011690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological effects of human gastrin I and II chemically modified at the C-terminal tetrapeptide amide.
    Galleyrand JC; Fulcrand P; Bali JP; Rodriguez M; Magous R; Laur J; Martinez J
    Peptides; 1992; 13(3):519-25. PubMed ID: 1523164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenylethylamide derivatives of the C-terminal tetrapeptide of gastrin. Potent inhibitors of gastrin-stimulated acid secretion.
    Martinez J; Rodriguez M; Bali JP; Laur J
    Int J Pept Protein Res; 1986 Nov; 28(5):529-35. PubMed ID: 3818170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological profile of a new peptidic gastrin antagonist.
    Lavezzo A; Bali JP; Magous R; Lignon MF; Nisato D; Laur J; Castro B; Martinez J
    Regul Pept; 1986 Sep; 15(2):111-9. PubMed ID: 3786833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-antigastrin activity relationships of new (R)-4-benzamido-5-oxopentanoic acid derivatives.
    Makovec F; Peris W; Revel L; Giovanetti R; Mennuni L; Rovati LC
    J Med Chem; 1992 Jan; 35(1):28-38. PubMed ID: 1732532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioactivity studies on new gastrin analogues.
    Haugen SE; Douglas AJ; Rønning B; Walker B; Sandvik AK; Murphy RF; Elmore DT; Waldum HL
    Scand J Gastroenterol; 1989 Jun; 24(5):577-80. PubMed ID: 2762757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Synthesis of peptides with gastrinlike activity. Studies on the structure-activity relationship of the natural hormone human little gastrin I].
    Göhring W; Moroder L; Borin G; Lobbia A; Bali JP; Wünsch E
    Hoppe Seylers Z Physiol Chem; 1984 Jan; 365(1):83-94. PubMed ID: 6714937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-affinity binding sites for gastrin on isolated rabbit gastric mucosal cells.
    Magous R; Bali JP
    Eur J Pharmacol; 1982 Aug; 82(1-2):47-54. PubMed ID: 6290232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of analogues of the Des-Phe-NH2 C-terminal hexapeptide of cholecystokinin showing gastrin antagonist activity.
    Laur J; Rodriguez M; Aumelas A; Bali JP; Martinez J
    Int J Pept Protein Res; 1986 Apr; 27(4):386-93. PubMed ID: 3710694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct requirements for activation at CCK-A and CCK-B/gastrin receptors: studies with a C-terminal hydrazide analogue of cholecystokinin tetrapeptide (30-33).
    Lin CW; Holladay MW; Barrett RW; Wolfram CA; Miller TR; Witte D; Kerwin JF; Wagenaar F; Nadzan AM
    Mol Pharmacol; 1989 Dec; 36(6):881-6. PubMed ID: 2601685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.